Prime Medicine, Inc. Human Resources Contracts & Agreements
14 Contracts & Agreements
- Bonus & Incentive Agreements (2 contracts)
- Compensation Agreements (1)
- Confidentiality Agreements (1)
- Consulting Agreements (2)
- Employment Agreements (8)
- Employment Agreement, effective as of January 17, 2024 (Filed With SEC on January 5, 2024)
- Amendment No. 1 to the Amended and Restated Employment Agreement, dated (Filed With SEC on November 3, 2023)
- Form of Executive Employment Agreement (Filed With SEC on October 13, 2022)
- 2022 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on October 13, 2022)
- Andrew Anzalone Confidentiality, Assignment and Nonsolicitation Agreement, dated October 16, 2020 (Filed With SEC on September 23, 2022)
- Amendment No. 1 to the Consulting Agreement between the Registrant and David Liu, dated October 22, 2021 (Filed With SEC on September 23, 2022)
- Consulting Agreement between the Registrant and David Liu, dated September 13, 2019 (Filed With SEC on September 23, 2022)
- Amended and Restated Employment Agreement, dated July 7, 2022, between the Registrant and Meredith Goldwasser (Filed With SEC on September 23, 2022)
- Amended and Restated Employment Agreement, dated July 7, 2022, between the Registrant and Carman Alenson (Filed With SEC on September 23, 2022)
- Amended and Restated Employment Agreement, dated July 11, 2022, between the Registrant and Ann Lee (Filed With SEC on September 23, 2022)
- Amended and Restated Employment Agreement, dated July 20, 2022, between the Registrant and Jeremy Duffield (Filed With SEC on September 23, 2022)
- Amended and Restated Employment Agreement, dated July 7, 2022, between the Registrant and Keith Gottesdiener (Filed With SEC on September 23, 2022)
- Non-Employee Director Compensation Policy (Filed With SEC on September 23, 2022)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on September 23, 2022)